Related Experiment Video
Updated: Feb 13, 2026

Visualization of Estrogen Receptors in Colons of Mice with TNBS-Induced Crohn's Disease using Immunofluorescence
Published on: March 12, 2020
Peroxisome proliferator-activated receptor gamma ligands suppress colon carcinogenesis induced by azoxymethane in
Emi Osawa1, Atsushi Nakajima, Koichiro Wada
1The Third Department of Internal Medicine, Yokohama City University School of Medicine, Japan.
Background & Aims:
Peroxisome proliferator-activated receptor gamma (PPARgamma) is known to regulate growth arrest and terminal differentiation of adipocytes and is used clinically as a new class of antidiabetic drugs. Recently, several studies have reported that treatment of cancer cells with PPARgamma ligands induces cell differentiation and apoptosis, suggesting a potential application as chemopreventive agents against carcinogenesis. However, contradictory results have been reported with regards to the biologic role of PPARgamma in carcinogenesis. Tanaka et al.(24) have recently reported the suppressive effect of a PPARgamma ligand, troglitazone (Tro), on the formation of aberrant crypt foci (ACF) in rats. In the present study, 3 different kinds of PPARgamma ligands were subjected to the experiments to confirm their suppressive effects on colon carcinogenesis.
Methods:
Three PPARgamma ligands, pioglitazone (Pio) (200 ppm), rosiglitazone (Rosi) (200 ppm), and Tro (1000 ppm) were investigated on the induction of ACF, a putative precancerous lesion of the colon, and colon tumor formation using an azoxymethane (AOM)-induced colon cancer model in BALB/c mice, and dose dependency of a PPARgamma ligand was also examined.
Results:
PPARgamma ligands reduced the ACF formation by AOM (10 mg/kg body weight) and induction of colon tumors were also markedly suppressed by a continuous feeding of Pio at 200 ppm.
Conclusions:
Our findings indicate that PPARgamma ligands are indeed potential chemopreventive agents for colon carcinogenesis.
Insights
PPARgamma ligands show promise in preventing colon cancer. Studies indicate these compounds can suppress aberrant crypt foci and reduce tumor formation, suggesting a role in chemoprevention.
Area of Science:
- Molecular biology and cancer research
- Pharmacology and drug development
Background:
- Peroxisome proliferator-activated receptor gamma (PPARgamma) regulates adipocyte differentiation and is used in antidiabetic drugs.
- PPARgamma ligands have shown potential in inducing cancer cell differentiation and apoptosis, suggesting chemopreventive applications.
- Contradictory findings exist regarding PPARgamma's role in carcinogenesis, necessitating further investigation.
Purpose of the Study:
- To investigate the chemopreventive effects of PPARgamma ligands on colon carcinogenesis.
- To confirm the suppressive effects of three different PPARgamma ligands on colon cancer development.
Main Methods:
- Three PPARgamma ligands (pioglitazone, rosiglitazone, troglitazone) were tested.
- An azoxymethane (AOM)-induced colon cancer model in BALB/c mice was used.
- Effects on aberrant crypt foci (ACF) formation and colon tumor development were assessed, including dose dependency.
Main Results:
- PPARgamma ligands significantly reduced ACF formation induced by AOM.
- Continuous feeding of pioglitazone (200 ppm) markedly suppressed colon tumor induction.
- The study examined the dose-dependent effects of PPARgamma ligands.
Conclusions:
- PPARgamma ligands demonstrate potential as chemopreventive agents against colon carcinogenesis.
- The findings support the use of PPARgamma ligands for colon cancer prevention strategies.
Related Concept Videos
Peroxisomes and Mitochondria
The peroxisome is a single membrane-bound cellular organelle that can perform several different functions, including lipid metabolism and chemical detoxification. The enzymes within...
Peroxisomes
G-protein Coupled Receptors
Ligand Binding and Linkage
Internal Receptors
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

